|
Volumn 103, Issue 17, 2011, Pages 1290-1291
|
CA-125: A biomarker put to the test
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CA 125 ANTIGEN;
TUMOR MARKER;
ALGORITHM;
CANCER MORTALITY;
CANCER RELAPSE;
CANCER RISK;
CANCER SCREENING;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC VALUE;
EARLY DIAGNOSIS;
HUMAN;
NOTE;
OVARY CANCER;
PRIORITY JOURNAL;
REFERENCE VALUE;
RISK ASSESSMENT;
SCREENING TEST;
SENSITIVITY AND SPECIFICITY;
TRANSVAGINAL ECHOGRAPHY;
TREATMENT RESPONSE;
BIOLOGICAL MARKERS;
CA-125 ANTIGEN;
CLINICAL TRIALS AS TOPIC;
ENDOMETRIOSIS;
FALSE POSITIVE REACTIONS;
FEMALE;
GYNECOLOGIC SURGICAL PROCEDURES;
HUMANS;
MASS SCREENING;
OVARIAN DISEASES;
OVARIAN NEOPLASMS;
PREGNANCY;
SENSITIVITY AND SPECIFICITY;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 80052675810
PISSN: 00278874
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djr344 Document Type: Note |
Times cited : (6)
|
References (0)
|